Sara Kenkare-Mitra

Insider Reports History

Entity
Individual
Location
C/O Alector, Inc, 131 Oyster Point Blvd, Suite 600, South San Francisco, CA
Signature
/s/ Marc Grasso, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sara Kenkare-Mitra:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Alector, Inc. President and Head of R&D Common Stock 292K $1.42M $4.88 Sep 3, 2024 Direct
Unicycive Therapeutics, Inc. Director Stock Options 180K Sep 5, 2023 Direct
Alector, Inc. President and Head of R&D Employee Stock Option (right to buy) 54.5K Oct 1, 2023 Direct

Insider Reports Filed by Sara Kenkare-Mitra

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALEC Alector, Inc. Sep 3, 2024 1 -$68K 4 Sep 4, 2024 President and Head of R&D
ALEC Alector, Inc. Jun 3, 2024 1 -$63.4K 4 Jun 4, 2024 President and Head of R&D
ALEC Alector, Inc. Mar 4, 2024 1 -$70.4K 4 Mar 5, 2024 President and Head of R&D
ALEC Alector, Inc. Dec 4, 2023 1 -$69.6K 4 Dec 6, 2023 President and Head of R&D
ALEC Alector, Inc. Oct 1, 2023 2 $0 4 Oct 3, 2023 President and Head of R&D
UNCY Unicycive Therapeutics, Inc. Sep 5, 2023 1 $0 4 Sep 7, 2023 Director
UNCY Unicycive Therapeutics, Inc. Sep 5, 2023 0 $0 3 Sep 7, 2023 Director
ALEC Alector, Inc. Sep 5, 2023 1 -$32.3K 4 Sep 6, 2023 President and Head of R&D
ALEC Alector, Inc. Jun 2, 2023 1 -$28.2K 4 Jun 5, 2023 President and Head of R&D
ALEC Alector, Inc. Mar 2, 2023 1 -$84.2K 4 Mar 3, 2023 President and Head of R&D
ALEC Alector, Inc. Oct 1, 2022 2 $0 4 Oct 4, 2022 President and Head of R&D
ALEC Alector, Inc. Jan 3, 2022 3 $0 4 Jan 5, 2022 President and Head of R&D
ALEC Alector, Inc. Dec 15, 2021 0 $0 3 Dec 16, 2021 President and Head of R&D